img

Global Ovarian Cancer Treatment Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ovarian Cancer Treatment Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
Ovarian Cancer Treatment Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ovarian Cancer Treatment Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ovarian Cancer Treatment Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ovarian Cancer Treatment Drugs key manufacturers include AstraZeneca, Roche, Tesaro, Clovis Oncology, Kazia Therapeutics and Polaris Pharma, etc. AstraZeneca, Roche, Tesaro are top 3 players and held % sales share in total in 2022.
Ovarian Cancer Treatment Drugs can be divided into Platinum Anticancer Drugs, Fluoropyrimidines, Anthracycline Antibiotics and Therapertic Antibody, etc. Platinum Anticancer Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Ovarian Cancer Treatment Drugs is widely used in various fields, such as Hospital, Clinic, Drugstore and Others, etc. Hospital provides greatest supports to the Ovarian Cancer Treatment Drugs industry development. In 2022, global % sales of Ovarian Cancer Treatment Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ovarian Cancer Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Roche
Tesaro
Clovis Oncology
Kazia Therapeutics
Polaris Pharma
Segment by Type
Platinum Anticancer Drugs
Fluoropyrimidines
Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)

Segment by Application


Hospital
Clinic
Drugstore
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ovarian Cancer Treatment Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ovarian Cancer Treatment Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ovarian Cancer Treatment Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ovarian Cancer Treatment Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ovarian Cancer Treatment Drugs introduction, etc. Ovarian Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ovarian Cancer Treatment Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Ovarian Cancer Treatment Drugs Market Overview
1.1 Ovarian Cancer Treatment Drugs Product Overview
1.2 Ovarian Cancer Treatment Drugs Market Segment by Type
1.2.1 Platinum Anticancer Drugs
1.2.2 Fluoropyrimidines
1.2.3 Anthracycline Antibiotics
1.2.4 Therapertic Antibody
1.2.5 Small Molecules Drug
1.2.6 Aromatase Inhibitors (Targeted Therapy Drug)
1.2.7 Anti-estrogens
1.2.8 Aromatase Inhibitors (Endocrine Therapy Drug)
1.3 Global Ovarian Cancer Treatment Drugs Market Size by Type
1.3.1 Global Ovarian Cancer Treatment Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Ovarian Cancer Treatment Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Ovarian Cancer Treatment Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2018-2024)
2 Global Ovarian Cancer Treatment Drugs Market Competition by Company
2.1 Global Top Players by Ovarian Cancer Treatment Drugs Sales (2018-2024)
2.2 Global Top Players by Ovarian Cancer Treatment Drugs Revenue (2018-2024)
2.3 Global Top Players by Ovarian Cancer Treatment Drugs Price (2018-2024)
2.4 Global Top Manufacturers Ovarian Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ovarian Cancer Treatment Drugs Market Competitive Situation and Trends
2.5.1 Ovarian Cancer Treatment Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Ovarian Cancer Treatment Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ovarian Cancer Treatment Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Ovarian Cancer Treatment Drugs Market
2.8 Key Manufacturers Ovarian Cancer Treatment Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ovarian Cancer Treatment Drugs Status and Outlook by Region
3.1 Global Ovarian Cancer Treatment Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Ovarian Cancer Treatment Drugs Historic Market Size by Region
3.2.1 Global Ovarian Cancer Treatment Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Ovarian Cancer Treatment Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Ovarian Cancer Treatment Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Ovarian Cancer Treatment Drugs Forecasted Market Size by Region
3.3.1 Global Ovarian Cancer Treatment Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Ovarian Cancer Treatment Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Ovarian Cancer Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Ovarian Cancer Treatment Drugs by Application
4.1 Ovarian Cancer Treatment Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drugstore
4.1.4 Others
4.2 Global Ovarian Cancer Treatment Drugs Market Size by Application
4.2.1 Global Ovarian Cancer Treatment Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Ovarian Cancer Treatment Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Ovarian Cancer Treatment Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2018-2024)
5 North America Ovarian Cancer Treatment Drugs by Country
5.1 North America Ovarian Cancer Treatment Drugs Historic Market Size by Country
5.1.1 North America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Ovarian Cancer Treatment Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Ovarian Cancer Treatment Drugs Sales in Value by Country (2018-2024)
5.2 North America Ovarian Cancer Treatment Drugs Forecasted Market Size by Country
5.2.1 North America Ovarian Cancer Treatment Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Ovarian Cancer Treatment Drugs Sales in Value by Country (2024-2034)
6 Europe Ovarian Cancer Treatment Drugs by Country
6.1 Europe Ovarian Cancer Treatment Drugs Historic Market Size by Country
6.1.1 Europe Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Ovarian Cancer Treatment Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Ovarian Cancer Treatment Drugs Sales in Value by Country (2018-2024)
6.2 Europe Ovarian Cancer Treatment Drugs Forecasted Market Size by Country
6.2.1 Europe Ovarian Cancer Treatment Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Ovarian Cancer Treatment Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Ovarian Cancer Treatment Drugs by Region
7.1 Asia-Pacific Ovarian Cancer Treatment Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Ovarian Cancer Treatment Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Ovarian Cancer Treatment Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Ovarian Cancer Treatment Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Ovarian Cancer Treatment Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Ovarian Cancer Treatment Drugs Sales in Value by Region (2024-2034)
8 Latin America Ovarian Cancer Treatment Drugs by Country
8.1 Latin America Ovarian Cancer Treatment Drugs Historic Market Size by Country
8.1.1 Latin America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Ovarian Cancer Treatment Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Ovarian Cancer Treatment Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Ovarian Cancer Treatment Drugs Forecasted Market Size by Country
8.2.1 Latin America Ovarian Cancer Treatment Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Ovarian Cancer Treatment Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Ovarian Cancer Treatment Drugs by Country
9.1 Middle East and Africa Ovarian Cancer Treatment Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Ovarian Cancer Treatment Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Ovarian Cancer Treatment Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Ovarian Cancer Treatment Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Ovarian Cancer Treatment Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Ovarian Cancer Treatment Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Ovarian Cancer Treatment Drugs Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche Ovarian Cancer Treatment Drugs Products Offered
10.2.5 Roche Recent Development
10.3 Tesaro
10.3.1 Tesaro Company Information
10.3.2 Tesaro Introduction and Business Overview
10.3.3 Tesaro Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Tesaro Ovarian Cancer Treatment Drugs Products Offered
10.3.5 Tesaro Recent Development
10.4 Clovis Oncology
10.4.1 Clovis Oncology Company Information
10.4.2 Clovis Oncology Introduction and Business Overview
10.4.3 Clovis Oncology Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Clovis Oncology Ovarian Cancer Treatment Drugs Products Offered
10.4.5 Clovis Oncology Recent Development
10.5 Kazia Therapeutics
10.5.1 Kazia Therapeutics Company Information
10.5.2 Kazia Therapeutics Introduction and Business Overview
10.5.3 Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Kazia Therapeutics Ovarian Cancer Treatment Drugs Products Offered
10.5.5 Kazia Therapeutics Recent Development
10.6 Polaris Pharma
10.6.1 Polaris Pharma Company Information
10.6.2 Polaris Pharma Introduction and Business Overview
10.6.3 Polaris Pharma Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Polaris Pharma Ovarian Cancer Treatment Drugs Products Offered
10.6.5 Polaris Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ovarian Cancer Treatment Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ovarian Cancer Treatment Drugs Industrial Chain Analysis
11.4 Ovarian Cancer Treatment Drugs Market Dynamics
11.4.1 Ovarian Cancer Treatment Drugs Industry Trends
11.4.2 Ovarian Cancer Treatment Drugs Market Drivers
11.4.3 Ovarian Cancer Treatment Drugs Market Challenges
11.4.4 Ovarian Cancer Treatment Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ovarian Cancer Treatment Drugs Distributors
12.3 Ovarian Cancer Treatment Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Platinum Anticancer Drugs
Table 2. Major Company of Fluoropyrimidines
Table 3. Major Company of Anthracycline Antibiotics
Table 4. Major Company of Therapertic Antibody
Table 5. Major Company of Small Molecules Drug
Table 6. Major Company of Aromatase Inhibitors (Targeted Therapy Drug)
Table 7. Major Company of Anti-estrogens
Table 8. Major Company of Aromatase Inhibitors (Endocrine Therapy Drug)
Table 9. Global Ovarian Cancer Treatment Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (K Units)
Table 11. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (US& Million)
Table 13. Global Ovarian Cancer Treatment Drugs Market Share in Value by Type (2018-2024)
Table 14. Global Ovarian Cancer Treatment Drugs Price by Type (2018-2024) & (USD/Unit)
Table 15. Global Ovarian Cancer Treatment Drugs Sales by Type (2024-2034) & (K Units)
Table 16. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type (2024-2034)
Table 17. Global Ovarian Cancer Treatment Drugs Sales by Type (2024-2034) & (US$ Million)
Table 18. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type (2024-2034)
Table 19. Global Ovarian Cancer Treatment Drugs Price by Type (2024-2034) & (USD/Unit)
Table 20. North America Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (K Units)
Table 21. North America Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Ovarian Cancer Treatment Drugs Sales (K Units) by Type (2018-2024)
Table 23. Europe Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Ovarian Cancer Treatment Drugs Sales (K Units) by Type (2018-2024)
Table 25. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Ovarian Cancer Treatment Drugs Sales (K Units) by Type (2018-2024)
Table 27. Latin America Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Ovarian Cancer Treatment Drugs Sales (K Units) by Type (2018-2024)
Table 29. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Ovarian Cancer Treatment Drugs Sales by Company (2018-2024) & (K Units)
Table 31. Global Ovarian Cancer Treatment Drugs Sales Share by Company (2018-2024)
Table 32. Global Ovarian Cancer Treatment Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Ovarian Cancer Treatment Drugs Revenue Share by Company (2018-2024)
Table 34. Global Market Ovarian Cancer Treatment Drugs Price by Company (2018-2024) & (USD/Unit)
Table 35. Global Ovarian Cancer Treatment Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Ovarian Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ovarian Cancer Treatment Drugs as of 2022)
Table 38. Date of Key Manufacturers Enter into Ovarian Cancer Treatment Drugs Market
Table 39. Key Manufacturers Ovarian Cancer Treatment Drugs Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Ovarian Cancer Treatment Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 42. Global Ovarian Cancer Treatment Drugs Sales by Region (2018-2024) & (K Units)
Table 43. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Ovarian Cancer Treatment Drugs Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Region (2018-2024)
Table 46. Global Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 47. Global Ovarian Cancer Treatment Drugs Sales by Region (2024-2034) & (K Units)
Table 48. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Region (2024-2034)
Table 49. Global Ovarian Cancer Treatment Drugs Sales by Region (2024-2034) & (US$ Million)
Table 50. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Region (2024-2034)
Table 51. Global Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 52. Global Ovarian Cancer Treatment Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 53. Global Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (K Units)
Table 54. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application (2018-2024)
Table 57. Global Ovarian Cancer Treatment Drugs Price by Application (2018-2024) & (USD/Unit)
Table 58. Global Ovarian Cancer Treatment Drugs Sales by Application (2024-2034) & (K Units)
Table 59. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application (2024-2034)
Table 60. Global Ovarian Cancer Treatment Drugs Sales by Application (2024-2034) & (US$ Million)
Table 61. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application (2024-2034)
Table 62. Global Ovarian Cancer Treatment Drugs Price by Application (2024-2034) & (USD/Unit)
Table 63. North America Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) (K Units)
Table 64. North America Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) (K Units)
Table 66. Europe Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) (K Units)
Table 68. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) (K Units)
Table 70. Latin America Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) (K Units)
Table 72. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (K Units)
Table 74. North America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2018-2024)
Table 77. North America Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (K Units)
Table 78. North America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2024-2034)
Table 79. North America Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (US$ Million)
Table 80. North America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2024-2034)
Table 81. Europe Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (K Units)
Table 82. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (K Units)
Table 86. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2024-2034)
Table 87. Europe Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (US$ Million)
Table 88. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2024-2034)
Table 89. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Region (2018-2024) & (K Units)
Table 90. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Region (2024-2034) & (K Units)
Table 94. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Region (2024-2034)
Table 95. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Value by Region (2024-2034)
Table 97. Latin America Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (K Units)
Table 98. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (K Units)
Table 102. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2024-2034)
Table 103. Latin America Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (US$ Million)
Table 104. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2024-2034)
Table 105. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (K Units)
Table 110. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Country (2024-2034)
Table 111. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country (2024-2034) & (US$ Million)
Table 112. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Value by Country (2024-2034)
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Introduction and Business Overview
Table 115. AstraZeneca Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. AstraZeneca Ovarian Cancer Treatment Drugs Product
Table 117. AstraZeneca Recent Development
Table 118. Roche Company Information
Table 119. Roche Introduction and Business Overview
Table 120. Roche Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Roche Ovarian Cancer Treatment Drugs Product
Table 122. Roche Recent Development
Table 123. Tesaro Company Information
Table 124. Tesaro Introduction and Business Overview
Table 125. Tesaro Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Tesaro Ovarian Cancer Treatment Drugs Product
Table 127. Tesaro Recent Development
Table 128. Clovis Oncology Company Information
Table 129. Clovis Oncology Introduction and Business Overview
Table 130. Clovis Oncology Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Clovis Oncology Ovarian Cancer Treatment Drugs Product
Table 132. Clovis Oncology Recent Development
Table 133. Kazia Therapeutics Company Information
Table 134. Kazia Therapeutics Introduction and Business Overview
Table 135. Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Kazia Therapeutics Ovarian Cancer Treatment Drugs Product
Table 137. Kazia Therapeutics Recent Development
Table 138. Polaris Pharma Company Information
Table 139. Polaris Pharma Introduction and Business Overview
Table 140. Polaris Pharma Ovarian Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Polaris Pharma Ovarian Cancer Treatment Drugs Product
Table 142. Polaris Pharma Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Ovarian Cancer Treatment Drugs Market Trends
Table 146. Ovarian Cancer Treatment Drugs Market Drivers
Table 147. Ovarian Cancer Treatment Drugs Market Challenges
Table 148. Ovarian Cancer Treatment Drugs Market Restraints
Table 149. Ovarian Cancer Treatment Drugs Distributors List
Table 150. Ovarian Cancer Treatment Drugs Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Ovarian Cancer Treatment Drugs Product Picture
Figure 2. Global Ovarian Cancer Treatment Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Ovarian Cancer Treatment Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Ovarian Cancer Treatment Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Platinum Anticancer Drugs
Figure 6. Global Platinum Anticancer Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Fluoropyrimidines
Figure 8. Global Fluoropyrimidines Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Anthracycline Antibiotics
Figure 10. Global Anthracycline Antibiotics Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Therapertic Antibody
Figure 12. Global Therapertic Antibody Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Small Molecules Drug
Figure 14. Global Small Molecules Drug Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Aromatase Inhibitors (Targeted Therapy Drug)
Figure 16. Global Aromatase Inhibitors (Targeted Therapy Drug) Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Anti-estrogens
Figure 18. Global Anti-estrogens Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Aromatase Inhibitors (Endocrine Therapy Drug)
Figure 20. Global Aromatase Inhibitors (Endocrine Therapy Drug) Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Global Ovarian Cancer Treatment Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 22. Global Ovarian Cancer Treatment Drugs Sales Market Share by Type in 2022 & 2034
Figure 23. North America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2022
Figure 24. North America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2022
Figure 25. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2022
Figure 29. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Ovarian Cancer Treatment Drugs Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Ovarian Cancer Treatment Drugs Revenue in 2022
Figure 35. Ovarian Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Hospital
Figure 37. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Clinic
Figure 39. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Drugstore
Figure 41. Global Drugstore Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Product Picture of Others
Figure 43. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 44. Global Ovarian Cancer Treatment Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 45. Global Ovarian Cancer Treatment Drugs Sales Market Share by Application in 2022 & 2034
Figure 46. North America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2022
Figure 47. North America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2022
Figure 48. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2022
Figure 52. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2022
Figure 53. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. Ovarian Cancer Treatment Drugs Manufacturing Cost Structure
Figure 57. Ovarian Cancer Treatment Drugs Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed